Vimarsana
Biggest News Aggregation in the World

Page 3 - Dror Ben Asher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dror Ben Asher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dror Ben Asher Today - Breaking & Trending Today

RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights - Vimarsana News

RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights

Q1/23 Talicia net revenues of $3.4 million; Cash balance of $28.8 million as of March 31, 2023[1]; Extinguishment of all debt obligations in exchange for the...

RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights - Vimarsana News

RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights

Having extinguished all debt and significantly reduced cost-base, RedHill is now focused on late-stage pipeline advancement, in collaboration with U.S. and...

RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program - Vimarsana News

RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program

The National Institutes of Health's (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical...

Investegate |RedHill Biopharma Announcements | RedHill Biopharma: RDHL Opaganib Selected by NIH RNCP For Development - Vimarsana News

Investegate |RedHill Biopharma Announcements | RedHill Biopharma: RDHL Opaganib Selected by NIH RNCP For Development

Investegate announcements from RedHill Biopharma, RDHL Opaganib Selected by NIH RNCP For Development

RedHill Biopharma Announces Q3/22 Results and Operational Highlights - Vimarsana News

RedHill Biopharma Announces Q3/22 Results and Operational Highlights

Non-binding agreement in principle reached with HCR on sale of Movantik to extinguish all debt obligations, to facilitate growth Q3/22 Net revenues of $17.6...